NewsRadar
Home
Research
Products & Services
Online Data Service
Deal Alert Service
Radar
Advanced Search
Add Company
Add Person
Customized Research
Weekly Newsletter
Online News
Events

Seventure (Formerly SPEF Venture)
SPEF Venture has been investing since 1997 mainly in information technology and life sciences companies. It provides financing at each stage of a company's development from seed capital to preIPO stage.

• Show past press releases
• Edit this company

CONTACT INFORMATION
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
5-7 Rue de Monttessuy
Paris Cedex 07 75340
France
+33 (0)1 5819 2270
+33 (0)1 5819 2280
http://www.seventure.fr
Jean-Patrick Demonsang
+33 (0)1 5819 2270

COMPANY FACTS
Type:
Capital managed:
Companies invested in:  
Investment managers:
Total staff size:
Number of offices:
Min. investment size:
Max. investment size:
Independent Investor (VC)
300 Mln Euro





Funding stages:
Geo. scope europe:Local, National
Investment distrib.:
Industry preferences:ICT

PARTNERS

  • Bruno Rivet
  • David Giallorenzo
  • Didier Piccino
  • Isabelle de Cremoux
  • Valerie Gombart

    PORTFOLIO

  • Eureka Soft (merged with Voxpilot)
  • Arkeia Software
  • Delia Systems
  • XIRING
  • Baracoda SA
  • Idtect
  • OPi SAS (Acquired be EUSA Pharma)
  • ETIAM Rennes
  • Convergence SA
  • Europe Technologies
  • DxO Labs
  • SWT (Merged with Captiva Software Corp.)
  • Meristem Therapeutics
  • Netinary
  • DocWave
  • PolySpace Technologies SA (Acquired by MathWorks)
  • QuesCom
  • Calendra (Acquired by BMC Software Inc.)
  • TGS
  • Sefas Innovation
  • Hypnotizer
  • Intrason
  • TripleHop Technologies
  • Aladdino.com Ltd (UK)
  • QuesCom
  • Absia
  • Streamcore System
  • Swapcom (acquired by Sicap)
  • Intranode
  • Touche Etoile
  • E-Mail Vision
  • CertEurope SA
  • TAK'ASIC S.A.
  • Eolring
  • Delia Systems
  • Mobiquid
  • BudgeTelecom
  • BioAlliance Pharma
  • Aladdino.com Ltd (UK)
  • Maballade.com
  • SDM Editions
  • Planfax

    FUNDS
    NameStatusClosingSize
    Banque Populaire Innovation 8ClosedDec 20030 K Euro

    REMARKS
    Invests in Life Sciences companies




  • Copyright 1999-2014
    Emerging Technology Research Europe Inc. All rights reserved. Legal Information.